6 research outputs found
SUBJECTIVE AGE AND SUBJECTIVE EVALUATION OF THE HEALTH OF WOMEN WITH BREAST CANCER
This article is devoted to the results of the study of the relationship between subjective age and subjective assessment of health among women with breast cancer. The analysis of the literature showed that subjective age is a predictor of death, mental wellness, assessment of life prospects (approach of death), possibility of coping with a bad trauma (e.g. oncological disease). The research included 170 women in the age of 31 to 85 (the average age is 56,5) diagnosed with breast cancer on different stages. Summarising received data, it should be noted that the women who feel rather danger than their chronological age address to own resources and, in general their subjective health assessment is connected with role functioning based on the emotional condition and general mental health. The women with adequate perception of their age have issues with role functioning connected with physical condition as well as the women who feel older than they actually are do. The results of this research expand a notion about potential predictors for breast cancer course, besides the results can be used for building the forecast of the disease course and its outcome
Pressure tuning of charge ordering in iron oxide
A Verwey-type charge-ordering transition in magnetite at 120βK leads to the formation of linear units of three iron ions with one shared electron, called trimerons. The recently-discovered iron pentoxide (FeO) comprising mixed-valent iron cations at octahedral chains, demonstrates another unusual charge-ordering transition at 150βK involving competing formation of iron trimerons and dimerons. Here, we experimentally show that applied pressure can tune the charge-ordering pattern in FeO and strongly affect the ordering temperature. We report two charge-ordered phases, the first of which may comprise both dimeron and trimeron units, whereas, the second exhibits an overall dimerization involving both the octahedral and trigonal-prismatic chains of iron in the crystal structure. We link the dramatic change in the charge-ordering pattern in the second phase to redistribution of electrons between the octahedral and prismatic iron chains, and propose that the average oxidation state of the iron cations can pre-determine a charge-ordering pattern
Comparative Study of the Aftereffect of CO2 Inhalation or Tiletamine–Zolazepam–Xylazine Anesthesia on Laboratory Outbred Rats and Mice
CO2 inhalation is currently the most common method of euthanasia for laboratory rats and mice, and it is often used for further terminal blood sampling for clinical biochemical assays. Lately, this method has been criticized due to animal welfare issues associated with some processes that develop after CO2 inhalation. The stress reaction and the value of the clinical laboratory parameters significantly depend on the used anesthetics, method, and the site of blood sampling. Especially in small rodents, an acute terminal state followed by a cascade of metabolic reactions that can affect the studied biochemical profile may develop and cause unnecessary suffering of animals. The aim of this study was to compare the stability of biochemical parameters of outbred Sprague Dawley rats and CD-1 mice serum collected after CO2 inhalation or the intramuscular injection of tiletamine–zolazepam–xylazine (TZX). The serum content of total protein and albumin, cholesterol, triglycerides, aspartate aminotransferase (AST), alanine aminotr ansferase (ALT), alkaline phosphatase (ALP), total bilirubin, and creatinine was decreased by the injection of TZX in comparison with CO2 inhalation. In addition, the levels of calcium, phosphates, chlorides and potassium were lowered by TZX vs. CO2 administration, while the level of sodium increased. Finally, the level of the majority of serum clinical biochemical parameters in rats and mice tend to be overestimated after CO2 inhalation, which may lead to masking the possible effect of anti-inflammatory drugs in animal tests. Injection anesthesia for small rodents with TZX is a more feasible method for terminal blood sampling, which also reduces the suffering of animals
Psychological Predictors of Favorable and Unfavorable Course of Stomach Cancer
Π Π°ΠΊ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΠΏΡΡΠΎΠ΅ ΠΌΠ΅ΡΡΠΎ ΡΡΠ΅Π΄ΠΈ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΡΠ΅ΠΌΡΡ
Π²ΠΈΠ΄ΠΎΠ² ΡΠ°ΠΊΠ° ΠΈ ΡΡΠΈΡΠ°Π΅ΡΡΡ ΡΡΠ΅ΡΡΠ΅ΠΉ ΠΏΠΎ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ ΠΏΡΠΈΡΠΈΠ½ΠΎΠΉ ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΠΈ ΠΎΡ ΡΠ°ΠΊΠ° Π² ΠΌΠΈΡΠ΅.
ΠΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°ΠΊΠΎΠΌ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° ΠΌΠΎΠ³ΡΡ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°ΡΡ
ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΈ ΡΡΠΈΠ»Π΅Π½ΠΈΡ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΡ
Π»ΠΈΠ±ΠΎ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΡ
ΡΡΠ»ΠΎΠ²ΠΈΠΉ ΡΠ°Π·Π²ΠΈΡΠΈΡ
ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, Π° ΡΠ°ΠΊΠΆΠ΅ Π΅Π³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ. Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β Π²ΡΡΠ²ΠΈΡΡ
ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΡ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΠΈ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»Π΅Π·Π½ΠΈ
Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°ΠΊΠΎΠΌ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²ΡΡΡΡΠΏΠΈΠ»ΠΈ:
ΡΠΊΠ°Π»Π° Π±Π°Π·ΠΈΡΠ½ΡΡ
ΡΠ±Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ, ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊ Β«Π‘ΠΏΠΎΡΠΎΠ±Ρ ΡΠΎΠ²Π»Π°Π΄Π°ΡΡΠ΅Π³ΠΎ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡΒ»,
ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊ Π»ΠΈΡΠ½ΠΎΡΡΠ½ΠΎΠΉ Π±Π΅ΡΠΏΠΎΠΌΠΎΡΠ½ΠΎΡΡΠΈ, ΡΠ΅ΡΡ ΠΆΠΈΠ·Π½Π΅ΡΡΠΎΠΉΠΊΠΎΡΡΠΈ, ΡΡΡΡΠΊΠΎΡΠ·ΡΡΠ½Π°Ρ
Π²Π΅ΡΡΠΈΡ ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ° ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ (SF-36), ΡΠ΅ΡΡ ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎΠΉ ΠΎΡΠΈΠ΅Π½ΡΠ°ΡΠΈΠΈ, ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊ
ΡΡΠΎΠ²Π½Ρ ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ. ΠΠ»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠΎΠ²ΠΎΠΊΡΠΏΠ½ΠΎΡΡΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ°ΠΊΠ° ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°, ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΡΡ
Π΄ΠΈΡΠΊΡΠΈΠΌΠΈΠ½Π°Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· (ΠΏΠΎΡΠ°Π³ΠΎΠ²ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄, Π»ΡΠΌΠ±Π΄Π° Π£ΠΈΠ»ΠΊΡΠ°). ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ Π½Π° Π±Π°Π·Π΅ ΠΠΠ£Π Β«Π§Π΅Π»ΡΠ±ΠΈΠ½ΡΠΊΠΈΠΉ ΠΎΠ±Π»Π°ΡΡΠ½ΠΎΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ΅Π½ΡΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ
ΠΈ ΡΠ΄Π΅ΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΒ» (Π§Π΅Π»ΡΠ±ΠΈΠ½ΡΠΊ, Π Π€). ΠΡΠ±ΠΎΡΠΊΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Ρ ΡΠ°ΠΊΠΎΠΌ
ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π½Π° ΡΠ°Π·Π½ΡΡ
ΡΡΠ°Π΄ΠΈΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Ρ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ (N=63) ΠΈ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ
(N=61) ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π±ΠΎΠ»Π΅Π·Π½ΠΈ. Π‘ ΠΏΠΎΠΌΠΎΡΡΡ Π΄ΠΈΡΠΊΡΠΈΠΌΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π±ΡΠ» ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½
ΠΏΠ΅ΡΠ΅ΡΠ΅Π½Ρ Π΄ΠΈΡΠΊΡΠΈΠΌΠΈΠ½Π°Π½ΡΠ½ΡΡ
ΠΏΠ΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
, ΠΊΠ»Π°ΡΡΠΈΡΠΈΡΠΈΡΡΡΡΠΈΡ
Π²ΡΠ±ΠΎΡΠΊΡ ΡΠ΅ΡΠΏΠΎΠ½Π΄Π΅Π½ΡΠΎΠ²
Ρ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ ΠΈ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ°ΠΊΠ° ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°: ΠΊΠΎΠ³Π½ΠΈΡΠΈΠ²Π½ΠΎΠ΅
ΡΠ±Π΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΎ ΡΠΏΡΠ°Π²Π΅Π΄Π»ΠΈΠ²ΠΎΡΡΠΈ ΠΎΠΊΡΡΠΆΠ°ΡΡΠ΅Π³ΠΎ ΠΌΠΈΡΠ°; ΠΊΠΎΠΏΠΈΠ½Π³-ΡΡΡΠ°ΡΠ΅Π³ΠΈΠΈ Β«ΠΊΠΎΠ½ΡΡΠΎΠ½ΡΠ°ΡΠΈΡΒ»
ΠΈ Β«ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡΒ»; ΡΠΎΠ»Π΅Π²ΠΎΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅, ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠ΅
ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ΠΌ, ΡΠΎΠ»Π΅Π²ΠΎΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅, ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠ΅ ΡΠΌΠΎΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΌ
ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ΠΌ, ΠΈ ΠΎΠ±ΡΠ΅Π΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π·Π΄ΠΎΡΠΎΠ²ΡΡ ΠΊΠ°ΠΊ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ; ΡΠ°ΠΌΠΎΠΎΡΠ΅Π½ΠΊΠ°; ΡΠΌΠΎΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΡ; Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½Π½ΠΎΡΡΡ ΠΊΠ°ΠΊ
ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ ΠΆΠΈΠ·Π½Π΅ΡΡΠΎΠΉΠΊΠΎΡΡΠΈ. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²,
ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΡΡΠΈΡ
Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠΌΡ/Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠΌΡ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΠΎΡΠΊΡΡΠ²Π°Π΅Ρ Π½ΠΎΠ²ΡΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π² ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π΅ ΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ
Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΈ Π² ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠΈ Π΅Π³ΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠΉ Π½Π°Π±ΠΎΡ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΡΠ΅ΠΌ ΠΈΠ»ΠΈ ΠΈΠ½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ,
ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½ Π΄Π»Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ, ΠΏΡΠΈΡ
ΠΎΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ
ΠΈ ΠΏΡΠΈΡ
ΠΎΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΏΡΠΈ ΡΠ°Π±ΠΎΡΠ΅ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌΠΈ ΡΠΎ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈStomach cancer ranks fifth among the most commonly diagnosed cancers and
the third leading cause of cancer mortality in the world. Psychological characteristics of
patients with stomach cancer can contribute to creating and strengthening both favorable
and unfavorable conditions of the cancer development as well as its course. The purpose of
the study is to identify psychological predictors of favorable and unfavorable course of the
disease in patients with gastric cancer. The research methods included the Scale of Basic
Beliefs, βStrategies of Coping Behaviorβ questionnaire, Personal Helplessness questionnaire,
Resilience test, Russian-language version of the Quality of Life questionnaire (SF-36),
Life Orientation test, Level of Subjective Control questionnaire. Discriminant analysis
(step-by-step method, Wilkes lambda) was used to determine the set of psychological
predictors associated with different courses of stomach cancer. The study was conducted on
the premises of Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
(Chelyabinsk, Russia). The research sample consisted of patients with stomach cancer
with a favorable (remission, stabilization; N=63) and unfavorable (generalization, relapse,
progression, second concomitant cancer, death; N=61) course of the disease. With the help
of discriminant analysis a list of discriminant variables was determined that allow to identify
the groups of respondents with a favorable and unfavorable course of stomach cancer:
cognitive belief about the justice of surrounding world; coping strategies βconfrontationβ
and βproblem solving planningβ; role functioning due to physical condition, role functioning
due to emotional state, and general health as indicators of subjective assessment of the
life quality; self-esteem; emotional stability; engagement as a component of resilience.
Revealing the psychological predictors of the course of cancer provides new opportunities
in a personalized approach to the cancer treatment, in obtaining positive results and
increasing its effectiveness. The obtained set of prognostic indicators of the cancer course
can be recommended for the medical, psychosocial and psychotherapeutic practice when
working with patients with malignant neoplasm
AICAR Improves Outcomes of Metabolic Syndrome and Type 2 Diabetes Induced by High-Fat Diet in C57Bl/6 Male Mice
The aim of the study was to investigate the effect of AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) on the consequences of metabolic syndrome and type 2 diabetes induced by the consumption of a high-fat diet (HFD) in male C57Bl/6 mice. Additionally, the animals from group 6 were administered Methotrexate (MTX) at a dose of 1 mg/kg in parallel with AICAR, which slows down the metabolism of AICAR. The animals were recorded with signs of metabolic syndrome and type 2 diabetes mellitus by recording their body weights, glucose and insulin levels, and the calculating HOMA-IRs. At the end of the study, at the end of the 13th week, during necropsy, the internal organs were assessed, the masses of the organs were recorded, and special attention was paid to visceral fat, assessing its amount and the mass of the fat surrounding epididymis. The biochemical parameters and histology of the internal organs and tissues were assessed. The animals showed signs of metabolic syndrome and type 2 diabetes, namely, weight gain, hyperglycemia, hyperinsulinemia, an increase in the amount and mass of abdominal fat, and metabolic disorders, all expressed in a pathological change in biochemical parameters and pathological changes in internal organs. The AICAR treatment led to a decrease in body weight, a decrease in the amount and mass of abdominal fat, and an improvement in the pathomorphological picture of internal organs. However, some hepatotoxic effects were observed when the animals, on a received standard diet (STD), were treated with AICAR starting from the first day of the study. The additional administration of MTX, an AICAR metabolic inhibitor, did not improve its efficacy. Thus, AICAR has therapeutic potential for the treatment of metabolic syndrome and type 2 diabetes